文献速递乳腺外科

低价值乳腺癌手术持续使用的机构间差异

Variations in Persistent Use of Low-Value Breast Cancer Surgery.
PubMed 文献 · JAMA Surg · 2021-01-01

结果显示腋窝淋巴结清扫和肿块切除再手术的实施率显著下降,而对侧预防性乳房切除和老年女性前哨淋巴结活检率上升;学术研究项目和高容量机构减少最明显,但各手术的机构间差异显著且不一致。

要点

  • 腋窝淋巴结清扫和肿块切除再手术的实施率显著下降,但对侧预防性乳房切除和老年女性前哨淋巴结活检率上升。
  • 学术研究项目和高容量机构在减少低价值手术方面表现最佳。
  • 各低价值手术的机构间差异显著,且机构在不同手术间的去实施表现不一致。

核心结论

  • 机构间差异揭示了低价值乳腺癌手术的去实施绩效差距,为针对每项手术的正式去实施努力提供了机会。
  • 多种机构层面特征与差异化的去实施和绩效相关。

研究设计与样本

  • 回顾性队列研究,使用美国国家癌症数据库(覆盖约70%新发癌症诊断,超过1500家机构)2004-2016年诊断为乳腺癌的18岁以上女性,纳入符合每项Choosing Wisely推荐标准的患者。
  • 通过随机截距分层逻辑回归计算每项手术的可靠性调整机构率,比较证据发布前后的变化。

主要发现

  • 腋窝淋巴结清扫和肿块切除再手术的实施率显著下降,而对侧预防性乳房切除和老年女性前哨淋巴结活检率在研究期间上升。
  • 学术研究项目和高容量机构总体在减少低价值手术方面表现最佳。
  • 每项低价值手术均存在显著的机构间差异:机构层面腋窝淋巴结清扫率范围为7%至47%,肿块切除再手术率范围为3%至62%,对侧预防性乳房切除率范围为9%至67%,前哨淋巴结活检率范围为25%至97%。
  • 四项手术中任意两项组合的Pearson相关系数均小于0.11,表明医院在四项手术的去实施表现上不一致;许多医院在一项手术上是高异常值但在另一项上是低异常值。

临床怎么用

  • 临床应关注本机构在低价值乳腺癌手术上的实施率,尤其对侧预防性乳房切除和老年女性前哨淋巴结活检的持续使用。
  • 去实施策略需针对每项手术分别制定,因机构在不同手术间的表现不一致。
  • 学术研究项目和高容量机构的经验可作为去实施参考。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Through the Choosing Wisely campaign, surgical specialties identified 4 low-value breast cancer operations. Preliminary data suggest varying rates of deimplementation and have identified patient-level and clinician-level determinants of continued overuse. However, little information exists about facility-level variation or determinants of differential deimplementation. OBJECTIVE: To identify variation and determinants of persistent use of low-value breast cancer surgical care. DESIGN, SETTING, AND PARTICIPANTS: Retrospective cohort study in which reliability-adjusted facility rates of each procedure were calculated using random-intercept hierarchical logistic regression before and after evidence demonstrated that each procedure was unnecessary. The National Cancer Database is a prospective cancer registry of patients encompassing approximately 70% of all new cancer diagnoses from more than 1500 facilities in the United States. Data were analyzed from November 2019 to August 2020. The registry included women 18 years and older diagnosed as having breast cancer between 2004 and 2016 and meeting inclusion criteria for each Choosing Wisely recommendation. MAIN OUTCOMES AND MEASURES: Rate of each low-value breast cancer procedure based on facility type and breast cancer volume categories before and after the release of data supporting each procedure's omission. RESULTS: The total cohort included 920 256 women with a median age of 63 years. Overall, 86% self-identified as White, 10% as Black, 3% as Asian, and 4.5% as Hispanic. Most women in this cohort were insured (51% private and 47% public), were living in a metropolitan or urban area (88% and 11%, respectively), and originated from the top half of income-earning households (65.5%). While there was significant deimplementation of axillary lymph node dissection and lumpectomy reoperation in response to guidelines supporting omission of these procedures, rates of contralateral prophylactic mastectomy and sentinel lymph node biopsy in older women increased during the study period. Academic research programs and high-volume facilities overall demonstrated the greatest reduction in use of these low-value procedures. There was significant interfacility variation for each low-value procedure. Facility-level axillary lymph node dissection rates ranged from 7% to 47%, lumpectomy reoperation rates ranged from 3% to 62%, contralateral prophylactic mastectomy rates ranged from 9% to 67%, and sentinel lymph node biopsy rates ranged from 25% to 97%. Pearson correlation coefficient for each combination of 2 of the 4 procedures was less than 0.11, suggesting that hospitals were not consistent in their deimplementation performance across all 4 procedures. Many were high outliers in one procedure but low outliers in another. CONCLUSIONS AND RELEVANCE: Interfacility variation demonstrates a performance gap and an opportunity for formal deimplementation efforts targeting each procedure. Several facility-level characteristics were associated with differential deimplementation and performance.

来源:JAMA Surg,查看原文。版权归原作者所有。

引用

  1. Wang T, Bredbeck BC, Sinco B, et al. Variations in Persistent Use of Low-Value Breast Cancer Surgery. JAMA Surg. 2021. PMID: 33533894. doi:10.1001/jamasurg.2020.6942

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。